ArticleScientific reports2022
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib.
Yanchao Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
79 papers cite itlatest 60 shown
this paperpooled itcites it